Please login to the form below

Not currently logged in
Email:
Password:

Contract research organisation PRA opens Singapore office

Continues its Asia-Pacific expansion with new centralised operations base

PRA has opened a new office in Singapore that will act as a centralised operations base for its activities in the region.

The US contract research organisation's new facility will provide monitoring, project management, safety reporting, feasibility and other services.

Helen Neal, PRA's director of clinical operations for Asia-Pacific, said: "Building our capability across the region with the centre in Singapore permits our sponsors to experience a wider range of services and expertise.

"This location provides our teams with access to experts and resources within their time zone, positively impacting our speed and quality of delivery on projects."

PRA has been steadily expanding its Asia-Pacific operations since 2000 and its operations in the region also include Korea, Taiwan, China, Hong Kong, Thailand, Australia, New Zealand, and India.

The expansion mirrors investments from the pharma industry in new research operations. Last year Merck & Co pledged $1.5bn to expand its presence in China and Bayer said it expects Asia to account for €11bn of sales by 2015.

24th February 2012

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
bmore group

OUR PROMISE: BETTER HEALTH FROM TRIAL TO TREATMENT.We are a full service, independent network of specialist agencies under one roof....

Latest intelligence

white house
Eliminating pharmaceutical rebates, is this déjà vu?
By Andrew Parece and Matthew Majewski...
Patients are ready to embrace decentralised clinical trials, are you?
Traditional clinical trial designs simply can’t withstand the impact of COVID-19. While before the pandemic, some in clinical research were beginning to adopt virtual components, the move towards designing hybrid...
Has the pandemic opened up a future of accelerated diagnosis and better care for rare disease patients?
The challenge with rare disease is in the name – it's rare, so awareness is limited and diagnosis hindered. Could a more virtual existence change this? A Medical Affairs viewpoint...

Infographics